Effects of sulforaphane on negative symptoms and cognitive impairments in chronic schizophrenia patients: A randomized double-blind trial
Authors:
- 13 March 2025
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 184, 464-472
Abstract
No abstract availableKeywords
Funding Information
- Hunan Provincial Natural Science Foundation (2022JJ40691)
- Central South University (19)
- National Natural Science Foundation of China (82072096)
- Science and Technology Program of Hunan Province (2024RC3055)
This publication has 57 references indexed in Scilit:
- The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptomsEuropean Archives of Psychiatry and Clinical Neuroscience, 2023
- Evaluating the effect of black myrobalan on cognitive, positive, and negative symptoms in patients with chronic schizophrenia: A randomized, double‐blind, placebo‐controlled trialPhytotherapy Research, 2021
- Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of SchizophreniaNeuroscience Bulletin, 2021
- Add-on pharmacotherapy for patients with first-episode schizophrenia: a clinical perspectiveEuropean Journal of Clinical Pharmacology, 2020
- Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic PathwaysThe American Journal of Human Genetics, 2019
- Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical FindingsCurrent Psychiatry Reports, 2019
- Inflammation, Antipsychotic Drugs, and Evidence for Effectiveness of Anti-inflammatory Agents in Schizophrenia2019
- Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostatBiomedicine & Pharmacotherapy, 2018
- Histone deacetylase inhibitor sulforaphane: The phytochemical with vibrant activity against prostate cancerBiomedicine & Pharmacotherapy, 2016
- Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitorsEuropean Archives of Psychiatry and Clinical Neuroscience, 2013